Jubilant Pharmova Limited
₹892.3+0.17%Apr 13, 3:45 PM IST
JUBLPHARMA•Health Technology•Pharmaceuticals: Major
Current Price
₹892.3+0.17%
Apr 13, 3:45 PM ISTMarket Cap₹14,203.9 Cr
Market Cap₹14,203.9 Cr
Business Overview
Jubilant Pharmova Limited operates through 6 main business divisions including Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Generics, CRDMO, Proprietary Novel Drugs.
Business Hierarchy Structure for Jubilant Pharmova Limited
- Jubilant Pharmova Limited
- Radiopharma
- Radiopharmaceuticals
- SPECT
- MAA
- DTPA
- Exametazime
- Sulfur Colloid
- Mertiatide
- Tc99m-DTPA
- Tc99m-MAA
- Tc99m-Gluceptate
- Tc99m-Sestamibi
- Sulfur Colloid
- Tc99m-Exametazime
- Tc99m-Mertiatide
- Tc99m-MDP
- PET
- Ruby-Fill®
- Pylarify
- Illuccix
- Neuraceq
- FDG
- Rb82
- F18
- Cu64
- Therapeutics (Tx)
- HICON® Sodium lodine | 131
- Pluvicto
- Lutathera
- Lu177
- Ac225
- Pb202
- SPECT
- Radiopharmacies
- Radiopharmaceuticals
- Allergy Immunotherapy
- Venom Extracts
- Honey Bee
- White-Faced Hornet
- Yellow Hornet
- Wasp
- Yellow Jacket
- Mixed Vespid allergies
- Allergenic Extracts
- Dog Extracts
- Cat Extracts
- Mite Extracts
- Tree Pollen Extracts
- Skin Testing Devices
- ComforTen
- Quintest
- Quintip
- Venom Extracts
- CDMO Sterile Injectables
- Sterile Fill and Finish Injectables
- Liquid Injectables
- Lyophilization Injectables
- Ophthalmic Offers
- Liquids
- Ointments
- Creams
- Ampoules
- Sterile Fill and Finish Injectables
- Generics
- CVS Therapeutic Area
- CNS Therapeutic Area
- Anti Allergic Therapeutic Area
- Steroids Therapeutic Area
- Multi-specialty Therapeutic Area
- CRDMO
- Drug Discovery Services
- Pre-Clinical Services
- Integrated Programs
- API Manufacturing
- CVS Therapeutic Area APIs
- CNS Therapeutic Area APIs
- Drug Discovery Services
- Proprietary Novel Drugs
- Oncology Programs
- Autoimmune Disorders Programs
- JBI-802 (CoREST Inhibitor)
- Radiopharma